We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Meaning of Life in HIV-infected Youths

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01644383
Recruitment Status : Completed
First Posted : July 19, 2012
Last Update Posted : August 18, 2016
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Logotherapy has never been evaluated in HIV-infected teenagers. In this study, we will evaluate the meaning of life by using The Purpose in Life Test and the affect of logotherapy in HIV infected youth at HIV-NAT, Thai Red Cross AIDS Research Centre and King Chulalongkorn Memorial Hospital.

Condition or disease Intervention/treatment
Meaning of Life Behavioral: logotherapy

Detailed Description:
In the HAART era, HIV infected children can live longer and will grow up to become teenagers. However, some may develop psychosocial problems because they have lost family members, experienced poverty, social discrimination etc. Being a normal teenager is tough and is the most complex period of his/her life. This is the period when most teenagers will find their identity and reasons for living. Therefore it is believed that interventions may help HIV-infected teenagers better deal with life. For this study, logotherapy, a therapy that will help a person to discover his/her purpose in life, live meaningful life, and attain self-esteem was used. The success of the intervention was evaluated by using The Purpose in Life Test.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Meaning in Life of Youth Infected With HIV
Study Start Date : February 2011
Primary Completion Date : June 2015
Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Treatment arm (logotherapy)
Participants in Arm I will attend the logotherapy group sessions by the trained psychologist for 4 visits (see Table II, III). The number of participants in group sessions will be 20 participants per group.
Behavioral: logotherapy
Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.
No Intervention: Control arm (general health education)
Participants in Arm II will attend the routine health education by the nurse. The number of participants in group session will be 20 participants per group.


Outcome Measures

Primary Outcome Measures :
  1. PIL score [ Time Frame: week 48 ]
    Change of PIL score at baseline and follow up visit between the two arms


Secondary Outcome Measures :
  1. QOL [ Time Frame: 48 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 24 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age 16-24 years
  2. HIV seropositive
  3. HIV disclosed
  4. Understand Thai language
  5. Parent signed written informed consent

Exclusion Criteria:

  1. Mental or psychological disorder or having active suicidal idea or attempt
  2. Having no permanent address
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01644383


Locations
Thailand
HIV-NAT, the Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Sponsors and Collaborators
The HIV Netherlands Australia Thailand Research Collaboration
Chulalongkorn University
Pediatric department, Chulalongkorn University, Bangkok, Thailand
South East Asia Research Collaboration with Hawaii
Wayne State University
University of Minnesota, MN
Investigators
Principal Investigator: Arunya Tuicomepee, PhD Chulalongkorn University
More Information

Additional Information:
Responsible Party: The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier: NCT01644383     History of Changes
Other Study ID Numbers: HIV-NAT 109
First Posted: July 19, 2012    Key Record Dates
Last Update Posted: August 18, 2016
Last Verified: August 2016

Keywords provided by The HIV Netherlands Australia Thailand Research Collaboration:
meaning of life
logotherapy
HIV-infected teenagers
adherence